Berlex’ Yaz Receives Another “Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite the setback, the firm continues to expect FDA approval for the low-dose oral contraceptive in the first quarter of 2006.
You may also be interested in...
Berlex’ YAZ Clears FDA For Contraception; April Launch Planned
A premenstrual dysphoric disorder indication for the low-dose version of Yasmin is still pending.
Berlex’ YAZ Clears FDA For Contraception; April Launch Planned
A premenstrual dysphoric disorder indication for the low-dose version of Yasmin is still pending.
Loestrin 24 Approved As First 24-Day Oral Contraceptive
Warner Chilcott beats out Berlex' Yaz as the first oral contraceptive approved in the U.S. with 24 active hormone days.